Posted by Michael Wonder on 20 Jun 2022
EFPIA and Vaccines Europe are deeply disappointed about the decision taken by World Trade Organization at the Ministerial Conference to endorse a TRIPS waiver for COVID-19 vaccines
17 June 2022 - Speaking about the waiver, EFPIA Director General, Nathalie Moll said. “The decision is a serious retrograde step in our collective ability to tackle the COVID-19 pandemic and future global health threats.
The last two years have underlined that the only effective response to pandemics is grounded in research, development and innovation. That ability to respond is built on having a solid IP framework.”
